Rekah Pharmaceutical Industry (TLV:REKA) Has A Somewhat Strained Balance Sheet
Sep 12
Israeli (TA) Pharma Industry Analysis
UpdatedSep 20, 2023
DataAggregated Company Financials
Companies8
- 7D3.8%
- 3M-8.5%
- 1Y-51.9%
- YTD-32.2%
Over the last 7 days, the Pharma industry has risen 2.4%, driven by gains in InterCure and Rekah Pharmaceutical Industry of 4.6% and 6.6%, respectively. In the past year, the industry is down 51%. Earnings are forecast to grow by 86% annually.
Industry Valuation and Performance
Has the Israeli Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 20 Sep 2023 | ₪701.9m | ₪958.8m | -₪209,843,054.00 | 14.1x | -3.3x | 0.7x |
| Fri, 18 Aug 2023 | ₪646.1m | ₪918.8m | -₪128,230,912.00 | 8.3x | -5x | 0.7x |
| Sun, 16 Jul 2023 | ₪672.6m | ₪918.8m | -₪124,687,171.00 | 8.8x | -5.4x | 0.7x |
| Tue, 13 Jun 2023 | ₪776.3m | ₪918.8m | -₪124,562,052.00 | 11x | -6.2x | 0.8x |
| Thu, 11 May 2023 | ₪831.5m | ₪887.2m | -₪121,765,866.00 | 8.7x | -6.8x | 0.9x |
| Sat, 08 Apr 2023 | ₪844.8m | ₪829.2m | -₪98,399,832.00 | 11.8x | -8.6x | 1x |
| Mon, 06 Mar 2023 | ₪880.6m | ₪815.6m | -₪72,001,205.00 | 13.7x | -12.2x | 1.1x |
| Wed, 01 Feb 2023 | ₪1.0b | ₪739.7m | -₪56,343,113.00 | 17.1x | -17.9x | 1.4x |
| Fri, 30 Dec 2022 | ₪952.4m | ₪739.7m | -₪57,545,238.00 | 16.6x | -16.6x | 1.3x |
| Sun, 27 Nov 2022 | ₪1.2b | ₪728.3m | -₪56,017,375.00 | 23.3x | -22.3x | 1.7x |
| Tue, 25 Oct 2022 | ₪1.3b | ₪689.4m | -₪60,910,166.00 | 31.7x | -21.5x | 1.9x |
| Thu, 22 Sep 2022 | ₪1.3b | ₪689.4m | -₪59,162,850.00 | 30x | -22x | 1.9x |
| Sat, 20 Aug 2022 | ₪1.6b | ₪781.4m | -₪105,565,244.00 | 35.3x | -15x | 2x |
| Mon, 18 Jul 2022 | ₪1.6b | ₪731.4m | -₪119,436,825.00 | 42.1x | -13.5x | 2.2x |
| Wed, 15 Jun 2022 | ₪1.6b | ₪731.4m | -₪119,492,709.00 | 41.8x | -13.4x | 2.2x |
| Fri, 13 May 2022 | ₪1.7b | ₪669.4m | -₪124,566,867.00 | 35.4x | -13.6x | 2.5x |
| Sun, 10 Apr 2022 | ₪1.9b | ₪662.6m | -₪119,904,014.00 | 37.8x | -15.8x | 2.9x |
| Tue, 08 Mar 2022 | ₪1.8b | ₪598.9m | -₪112,324,115.00 | 49.2x | -16.3x | 3.1x |
| Thu, 03 Feb 2022 | ₪1.8b | ₪598.9m | -₪96,648,991.00 | 50.5x | -19.1x | 3.1x |
| Sat, 01 Jan 2022 | ₪1.9b | ₪598.9m | -₪95,783,207.00 | 51.3x | -19.5x | 3.1x |
| Mon, 29 Nov 2021 | ₪2.1b | ₪551.1m | -₪163,450,732.00 | 49.4x | -12.9x | 3.8x |
| Wed, 27 Oct 2021 | ₪2.2b | ₪522.6m | -₪146,671,723.00 | 30.3x | -15.2x | 4.3x |
| Fri, 24 Sep 2021 | ₪2.4b | ₪515.1m | -₪150,068,395.00 | 28.3x | -15.7x | 4.6x |
| Sun, 22 Aug 2021 | ₪2.2b | ₪499.0m | -₪147,462,423.50 | 26.7x | -15.2x | 4.5x |
| Fri, 09 Jul 2021 | ₪2.4b | ₪499.0m | -₪147,462,423.50 | 29.3x | -16.6x | 4.9x |
| Thu, 01 Apr 2021 | ₪2.1b | ₪466.6m | -₪189,880,366.50 | 27.4x | -10.9x | 4.4x |
| Sun, 03 Jan 2021 | ₪1.8b | ₪442.0m | -₪259,485,185.20 | 24.8x | -7x | 4.1x |
| Wed, 07 Oct 2020 | ₪1.6b | ₪384.0m | -₪288,523,540.95 | 29.6x | -5.6x | 4.2x |
Price to Earnings Ratio
-5.6x
Current Industry PE
- Investors are pessimistic on the Israeli Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 3.0x is higher than the industry's current PS ratio of 0.72x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 36% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Comparison
How does Israeli Pharma compare with similar industries?
| IL Market | -0.36% | |
| Healthcare | 1.17% | |
| Pharma | 3.76% | |
| Pharma | 3.76% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| REKA Rekah Pharmaceutical Industry | ₪17.69 | 6.6% +₪12.4m | -6.6% | PS0.7x | |
| INCR InterCure | ₪6.42 | 4.3% +₪12.1m | -60.3% | PE14x | |
| TKUN Tikun Olam-Cannbit Pharmaceuticals | ₪0.36 | 6.2% +₪1.7m | -82.4% | PS0.6x | |
| SEMG Seach Medical Group | ₪1.74 | 1.7% +₪986.7k | -40.1% | PS0.4x |
